Biological Response Modifiers Advisory Committee

Meeting #35 - Teleconference

June 9, 2003

National Institutes of Health, Building 29A, Room 1A09






1:30 p.m.            Welcome and Introductions

                                                Mahendra Rao, M.D., Ph.D., Acting Chair


1:40                 Conflict of Interest Meeting Statement

                                                Gail Dapolito, Executive Secretary


1:45                 FDA Introductory Remarks

Philip Noguchi, M.D.


                        Laboratory Presentations   

                                    Laboratory of Stem Cell Biology

1:50                                         Steven Bauer, Ph.D.


                                    Laboratory of Immunology and Developmental Biology

2:00                                         Deborah Hursh, Ph.D.

2:10                                         Malcolm Moos, M.D., Ph.D.

2:20                                         Suzanne Epstein, Ph.D.


2:30                 Open Public Hearing


3:30                 Closed Committee Discussion of Report and Vote


4:30 p.m.            Adjourn